Bio Essence Corp
BIOE· OTC
Filed May 11, 2021 · 10-Q · 41 days after period end · 0001213900-21-025624
| Metric | Q1 2021 | Q1 2020 |
|---|---|---|
| Revenue | $212.03K | $306.35K |
| Net Income | -$210.36K | -$117.14K |
| EPS Diluted | -$0.01 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio Essence Corp · CIK 1723059 · Engraved from SEC EDGAR
ended Mar 31, 2021 · filed May 11, 2021 · 41 d after period end